1. Product Overview
2. Research Methodology
3. Voice of Customer
4. Impact of COVID-19
on Global Ophthalmic Drugs Market
5.
Executive Summary
6. Ophthalmic Drugs
Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Drug Class (Anti-Inflammatory Drugs, Anti-Infection
Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, Others)
6.2.2. By Indication (Dry Eye, Eye Allergy, Glaucoma, Eye
Infection, Others)
6.2.3. By Product Type (OTC Drugs v/s Prescription Drugs)
6.2.4. By Dosage Form (Gels, Ointments, Eye Solutions, Eye
Drops, Tablets &Capsules)
6.2.5. By Route of Administration (Topical, Ocular, Systemic)
6.2.6. By Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, Online Pharmacy)
6.2.7. By Company (2021)
6.2.8. By Region
6.3. Product Market Map
7. North America
Ophthalmic Drugs Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Indication
7.2.3. By Product Type
7.2.4. By Dosage Form
7.2.5. By Route of
Administration
7.2.6. By Distribution
Channel
7.2.7. By Country
7.3.
North America: Country Analysis
7.3.1. United States
Ophthalmic Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug Class
7.3.1.2.2.
By Indication
7.3.1.2.3.
By Product Type
7.3.1.2.4.
By Dosage Form
7.3.1.2.5.
By Route of Administration
7.3.1.2.6.
By Distribution Channel
7.3.2. Canada Ophthalmic
Drugs Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug Class
7.3.2.2.2.
By Indication
7.3.2.2.3.
By Product Type
7.3.2.2.4.
By Dosage Form
7.3.2.2.5.
By Route of Administration
7.3.2.2.6.
By Distribution Channel
7.3.3. Mexico Ophthalmic
Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug Class
7.3.3.2.2.
By Indication
7.3.3.2.3.
By Product Type
7.3.3.2.4.
By Dosage Form
7.3.3.2.5.
By Route of Administration
7.3.3.2.6.
By Distribution Channel
8. Europe Ophthalmic
Drugs Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Indication
8.2.3. By Product Type
8.2.4. By Dosage Form
8.2.5. By Route of Administration
8.2.6. By Distribution
Channel
8.2.7. By Country
8.3.
Europe: Country Analysis
8.3.1. Germany Ophthalmic
Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug Class
8.3.1.2.2.
By Indication
8.3.1.2.3.
By Product Type
8.3.1.2.4.
By Dosage Form
8.3.1.2.5.
By Route of Administration
8.3.1.2.6.
By Distribution Channel
8.3.2. United Kingdom
Ophthalmic Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug Class
8.3.2.2.2.
By Indication
8.3.2.2.3.
By Product Type
8.3.2.2.4.
By Dosage Form
8.3.2.2.5.
By Route of Administration
8.3.2.2.6.
By Distribution Channel
8.3.3. France Ophthalmic
Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug Class
8.3.3.2.2.
By Indication
8.3.3.2.3.
By Product Type
8.3.3.2.4.
By Dosage Form
8.3.3.2.5.
By Route of Administration
8.3.3.2.6.
By Distribution Channel
8.3.4. Italy Ophthalmic
Drugs Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Drug Class
8.3.4.2.2.
By Indication
8.3.4.2.3.
By Product Type
8.3.4.2.4.
By Dosage Form
8.3.4.2.5.
By Route of Administration
8.3.4.2.6.
By Distribution Channel
8.3.5. Spain Ophthalmic
Drugs Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Drug Class
8.3.5.2.2.
By Indication
8.3.5.2.3.
By Product Type
8.3.5.2.4.
By Dosage Form
8.3.5.2.5.
By Route of Administration
8.3.5.2.6.
By Distribution Channel
8.3.6. Belgium Ophthalmic
Drugs Market Outlook
8.3.6.1.
Market Size & Forecast
8.3.6.1.1.
By Value
8.3.6.2.
Market Share & Forecast
8.3.6.2.1.
By Drug Class
8.3.6.2.2.
By Indication
8.3.6.2.3.
By Product Type
8.3.6.2.4.
By Dosage Form
8.3.6.2.5.
By Route of Administration
8.3.6.2.6.
By Distribution Channel
8.3.7. Sweden Ophthalmic
Drugs Market Outlook
8.3.7.1.
Market Size & Forecast
8.3.7.1.1.
By Value
8.3.7.2.
Market Share & Forecast
8.3.7.2.1.
By Drug Class
8.3.7.2.2.
By Indication
8.3.7.2.3.
By Product Type
8.3.7.2.4.
By Dosage Form
8.3.7.2.5.
By Route of Administration
8.3.7.2.6.
By Distribution Channel
8.3.8. Switzerland
Ophthalmic Drugs Market Outlook
8.3.8.1.
Market Size & Forecast
8.3.8.1.1.
By Value
8.3.8.2.
Market Share & Forecast
8.3.8.2.1.
By Drug Class
8.3.8.2.2.
By Indication
8.3.8.2.3.
By Product Type
8.3.8.2.4.
By Dosage Form
8.3.8.2.5.
By Route of Administration
8.3.8.2.6.
By Distribution Channel
9. Asia-Pacific
Ophthalmic Drugs Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Indication
9.2.3. By Product Type
9.2.4. By Dosage Form
9.2.5. By Route of
Administration
9.2.6. By Distribution
Channel
9.2.7. By Country
9.3.
Asia-Pacific: Country Analysis
9.3.1. Japan Ophthalmic
Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug Class
9.3.1.2.2.
By Indication
9.3.1.2.3.
By Product Type
9.3.1.2.4.
By Dosage Form
9.3.1.2.5.
By Route of Administration
9.3.1.2.6.
By Distribution Channel
9.3.2. China Ophthalmic
Drugs Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Drug Class
9.3.2.2.2.
By Indication
9.3.2.2.3.
By Product Type
9.3.2.2.4.
By Dosage Form
9.3.2.2.5.
By Route of Administration
9.3.2.2.6.
By Distribution Channel
9.3.3. India Ophthalmic
Drugs Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Drug Class
9.3.3.2.2.
By Indication
9.3.3.2.3.
By Product Type
9.3.3.2.4.
By Dosage Form
9.3.3.2.5.
By Route of Administration
9.3.3.2.6.
By Distribution Channel
9.3.4. South Korea
Ophthalmic Drugs Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Drug Class
9.3.4.2.2.
By Indication
9.3.4.2.3.
By Product Type
9.3.4.2.4.
By Dosage Form
9.3.4.2.5.
By Route of Administration
9.3.4.2.6.
By Distribution Channel
9.3.5. Australia Ophthalmic
Drugs Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Drug Class
9.3.5.2.2.
By Indication
9.3.5.2.3.
By Product Type
9.3.5.2.4.
By Dosage Form
9.3.5.2.5.
By Route of Administration
9.3.5.2.6.
By Distribution Channel
9.3.6. Singapore Ophthalmic
Drugs Market Outlook
9.3.6.1.
Market Size & Forecast
9.3.6.1.1.
By Value
9.3.6.2.
Market Share & Forecast
9.3.6.2.1.
By Drug Class
9.3.6.2.2.
By Indication
9.3.6.2.3.
By Product Type
9.3.6.2.4.
By Dosage Form
9.3.6.2.5.
By Route of Administration
9.3.6.2.6.
By Distribution Channel
9.3.7. Indonesia Ophthalmic
Drugs Market Outlook
9.3.7.1.
Market Size & Forecast
9.3.7.1.1.
By Value
9.3.7.2.
Market Share & Forecast
9.3.7.2.1.
By Drug Class
9.3.7.2.2.
By Indication
9.3.7.2.3.
By Product Type
9.3.7.2.4.
By Dosage Form
9.3.7.2.5.
By Route of Administration
9.3.7.2.6.
By Distribution Channel
10. South America
Ophthalmic Drugs Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Indication
10.2.3. By Product Type
10.2.4. By Dosage Form
10.2.5. By Route of
Administration
10.2.6. By Distribution
Channel
10.2.7. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Ophthalmic
Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Drug Class
10.3.1.2.2.
By Indication
10.3.1.2.3.
By Product Type
10.3.1.2.4.
By Dosage Form
10.3.1.2.5.
By Route of Administration
10.3.1.2.6.
By Distribution Channel
10.3.2. Argentina Ophthalmic
Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Drug Class
10.3.2.2.2.
By Indication
10.3.2.2.3.
By Product Type
10.3.2.2.4.
By Dosage Form
10.3.2.2.5.
By Route of Administration
10.3.2.2.6.
By Distribution Channel
10.3.3. Colombia Ophthalmic
Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Drug Class
10.3.3.2.2.
By Indication
10.3.3.2.3.
By Product Type
10.3.3.2.4.
By Dosage Form
10.3.3.2.5.
By Route of Administration
10.3.3.2.6.
By Distribution Channel
11. Middle East and
Africa Ophthalmic Drugs Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Drug Class
11.2.2. By Indication
11.2.3. By Product Type
11.2.4. By Dosage Form
11.2.5. By Route of
Administration
11.2.6. By Distribution
Channel
11.2.7. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa
Ophthalmic Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Drug Class
11.3.1.2.2.
By Indication
11.3.1.2.3.
By Product Type
11.3.1.2.4.
By Dosage Form
11.3.1.2.5.
By Route of Administration
11.3.1.2.6.
By Distribution Channel
11.3.2. Saudi Arabia
Ophthalmic Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Drug Class
11.3.2.2.2.
By Indication
11.3.2.2.3.
By Product Type
11.3.2.2.4.
By Dosage Form
11.3.2.2.5.
By Route of Administration
11.3.2.2.6.
By Distribution Channel
11.3.3. UAE Ophthalmic Drugs
Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Drug Class
11.3.3.2.2.
By Indication
11.3.3.2.3.
By Product Type
11.3.3.2.4.
By Dosage Form
11.3.3.2.5.
By Route of Administration
11.3.3.2.6.
By Distribution Channel
11.3.4. Qatar Ophthalmic
Drugs Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1.
By Drug Class
11.3.4.2.2.
By Indication
11.3.4.2.3.
By Product Type
11.3.4.2.4.
By Dosage Form
11.3.4.2.5.
By Route of Administration
11.3.4.2.6.
By Distribution Channel
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Competitive
Landscape
14.1.
AbbVie Inc. (Allergan)
14.2.
Bausch Health Companies Inc.
14.3.
Johnson & Johnson
14.4.
F. Hoffmann-La Roche Ltd.
14.5.
Hoya Corporation
14.6.
Novartis AG
14.7.
Pfizer Inc.
14.8.
Regeneron Pharmaceuticals Inc.
14.9.
Santen Pharmaceutical Co. Ltd.
14.10.
Alcon Inc.
14.11.
Teva Pharmaceuticals Industries Ltd.
14.12.
Sun Pharmaceutical Industries Ltd.
14.13.
Cipla Ltd.
14.14.
Merck & Co., Inc.
14.15.
Coherus Biosciences, Inc.
15.
Strategic
Recommendations